Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.21.3 (
deoxyribonuclease
)
1,528
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A RecA/
Rad51
homologue from Pyrococcus kodakaraensis KOD1 (Pk-REC) is the smallest protein among various RecA/
Rad51
homologues. Nevertheless, Pk-Rec is a super multifunctional protein and shows a
deoxyribonuclease
activity. This
deoxyribonuclease
activity was inhibited by 3 mM or more ATP, suggesting that the catalytic centers of the ATPase and
deoxyribonuclease
activities are overlapped. To examine whether these two enzymatic activities share the same active site, a number of site-directed mutations were introduced into Pk-REC and the ATPase and
deoxyribonuclease
activities of the mutant proteins were determined. The mutant enzyme in which double mutations Lys-33 to Ala and Thr-34 to Ala were introduced, fully lost both of these activities, indicating that Lys-33 and/or Thr-34 are important for both ATPase and
deoxyribonuclease
activities. The mutation of Asp-112 to Ala slightly and almost equally reduced both ATPase and
deoxyribonuclease
activities. In addition, the mutation of Glu-54 to Gln did not seriously affect the ATPase,
deoxyribonuclease
, and UV tolerant activities. These results strongly suggest that the active sites of the ATPase and
deoxyribonuclease
activities of Pk-REC are common. It is noted that unlike Glu-96 in Escherichia coli RecA, which has been proposed to be a catalytic residue for the ATPase activity, the corresponding residual Glu-54 in Pk-REC is not involved in the catalytic function of the protein.
...
PMID:A unique DNase activity shares the active site with ATPase activity of the RecA/Rad51 homologue (Pk-REC) from a hyperthermophilic archaeon. 1006 83